Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,596 | 5,345 | 3,631 | 4,175 | 6,744 |
| Receivables | 19,921 | 19,578 | 20,979 | 22,351 | 21,420 |
| Inventories | 19,955 | 21,231 | 22,209 | 22,216 | 22,343 |
| Income taxes - deferred | N/A | 0 | 0 | 0 | 42 |
| TOTAL | $45,472 | $46,154 | $46,819 | $48,742 | $50,549 |
| Non-Current Assets | |||||
| PPE Net | 4,296 | 5,267 | 5,641 | 5,733 | 5,902 |
| Intangibles | 18,680 | 20,088 | 20,842 | 21,761 | 62,452 |
| Other Non-Current Assets | 39,317 | 40,667 | 40,783 | 41,644 | 1,147 |
| TOTAL | $62,293 | $66,022 | $67,266 | $69,138 | $69,501 |
| Total Assets | $107,765 | $112,176 | $114,085 | $117,880 | $120,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,372 | 2,374 | 2,389 | 2,376 | 2,364 |
| Accounts payable and accrued liabilities | 6,196 | 6,142 | 6,577 | 6,172 | 8,782 |
| Accrued Expenses | 4,773 | 4,719 | 4,196 | 5,857 | 4,311 |
| Other current liabilities | 760 | 478 | 775 | 708 | 868 |
| TOTAL | $14,601 | $14,442 | $14,850 | $15,896 | $19,323 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,374 | 12,668 | 13,774 | 14,772 | 16,369 |
| Deferred Revenues | 500 | 729 | 913 | 783 | 752 |
| Other Non-Current Liabilities | 3,177 | 2,643 | 2,728 | 2,902 | 2,985 |
| TOTAL | $20,968 | $21,843 | $22,572 | $23,789 | $23,129 |
| Total Liabilities | $35,569 | $36,285 | $37,422 | $39,685 | $42,452 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,583 | 34,374 | 34,313 | 34,070 | 34,042 |
| Common Shares | 418 | 417 | 417 | 416 | 416 |
| Retained earnings | -116,030 | -114,710 | -113,072 | -112,359 | -111,723 |
| Other shareholders' equity | -16,326 | -12,948 | -12,782 | -10,959 | -11,552 |
| TOTAL | $72,196 | $75,891 | $76,663 | $78,195 | $77,598 |
| Total Liabilities And Equity | $107,765 | $112,176 | $114,085 | $117,880 | $120,050 |